Alta efficacia del trattamento degli emangiomi del neonato e del lattante con interferon alfa-2a: Risultati preliminari

Translated title of the contribution: High efficacy in the interferon alfa-2a treatment of hemangiomas of newborns and babies: Preliminary results

G. Deb, R. Cozza, P. Bagolan, C. Boglino, C. De Stefano, F. Ferro, D. Portaleone, P. Vadala, A. Donfrancesco

Research output: Contribution to journalArticle

Abstract

Hemangiomas of infants and children have been successfully treated by interferon as salvage therapy after failure of standard surgical, irradiation, or steroid therapy. In this study of 28 infants and children, we have conclusively demonstrated that interferon alfa-2a is a safe, practical, and effective primary therapy for hemangiomas. The treatment appears to remain effective, and in the rare instance of recurrence after treatment was stopped, additional regression can be obtained. These observations provide encouragement for use of interferon alfa-2a as primary therapy for infantile and childhood hemangiomas.

Original languageItalian
Pages (from-to)39-44
Number of pages6
JournalRivista Italiana di Pediatria
Volume23
Issue number1
Publication statusPublished - 1997

    Fingerprint

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Deb, G., Cozza, R., Bagolan, P., Boglino, C., De Stefano, C., Ferro, F., Portaleone, D., Vadala, P., & Donfrancesco, A. (1997). Alta efficacia del trattamento degli emangiomi del neonato e del lattante con interferon alfa-2a: Risultati preliminari. Rivista Italiana di Pediatria, 23(1), 39-44.